XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.2
SCHEDULE OF FAIR VALUE PRICING MODEL (Details)
Jun. 30, 2023
Integer
Mar. 31, 2023
Integer
Jan. 09, 2023
Integer
Measurement Input, Share Price [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Derivative liability measurement input [1] 0.51 0.34 1.44
Measurement Input, Expected Term [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Contractual term (years) [2] 5 years 5 years 3 months 18 days 5 years 6 months
Measurement Input, Risk Free Interest Rate [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Derivative liability measurement input 4.1 3.5 3.6
Measurement Input, Price Volatility [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Derivative liability measurement input 100 100 100
Measurement Input, Expected Dividend Rate [Member]      
Fair Value Measurement Inputs and Valuation Techniques [Line Items]      
Derivative liability measurement input 0 0 0
[1] Based on the trading value of common stock of Vivos Therapeutics, Inc. as of January 9, 2023 and each presented period ending date.
[2] The valuation of warrants is based on the expected term.